CellaVision Forecast, price target & analysts
CellaVision Target price 2026 - Analyst rating & recommendation
CellaVision Classifications & Recommendation
CellaVision Price Target
| Target Price | kr204.00 |
| Price | kr167.80 |
| Potential |
21.57%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target CellaVision 2027 .
The average CellaVision target price is kr204.00.
This is
21.57%
register free of charge
kr215.25
28.28%
register free of charge
kr181.80
8.34%
register free of charge
|
|
| A rating was issued by 9 analysts: 7 Analysts recommend CellaVision to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CellaVision stock has an average upside potential 2027 of
21.57%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million kr | 758.97 | 783.36 |
| 4.94% | 3.21% | |
| EBITDA Margin | 29.92% | 29.36% |
| 7.50% | 1.86% | |
| Net Margin | 20.17% | 18.43% |
| 3.66% | 8.62% |
4 Analysts have issued a sales forecast CellaVision 2026 . The average CellaVision sales estimate is
This results in the following potential growth metrics:
4 CellaVision Analysts have issued a net profit forecast 2026. The average CellaVision net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 6.42 | 6.05 |
| 8.81% | 5.76% | |
| P/E | 27.85 | |
| EV/Sales | 5.10 |
4 Analysts have issued a CellaVision forecast for earnings per share. The average CellaVision EPS is
This results in the following potential growth metrics and future valuations:
Current CellaVision Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Jul 20 2026 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Jul 20 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Jul 07 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Jul 06 2026 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | May 04 2026 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | May 03 2026 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Feb 09 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Jul 20 2026 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Jul 20 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Jul 07 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Jul 06 2026 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
May 04 2026 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
May 03 2026 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Feb 09 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
